J.P. Morgan discloses Kangji Medical share dealings amid privatization

J.P. Morgan Securities PLC, an associate connected with the offeror for Kangji Medical Holdings Limited, has disclosed dealings in the company's shares on August 26, 2025. These transactions occurred as part of a privatization by way of scheme of arrangement. The firm made two separate purchases of Kangji Medical shares for its own account, related to hedging Delta 1 products from unsolicited client-driven orders.

The first purchase involved 4,000 shares for a total of $34,711.42, with prices ranging from a high of $8.69 to a low of $8.65. The second, larger purchase comprised 64,500 shares for a total of $560,298.55, with prices ranging from $8.68 to $8.67. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.